Japan's Eisai to buy US MGI Pharma for $3.9 bln Washington Post

Japan's Eisai to buy US MGI Pharma for $3.9 bln Washington Post - United
States Big-ticket biotech deals this year include astrazeneca buying
medimmune for $15.6 billion and Celgene acquiring Pharmion , a rival of MGI, for $2.9
billion. ...

http://www.washingtonpost.com/wp-dyn/content/article/2007/12/10/AR200712100
0176.html

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://www.washingtonpost.com/wp-dyn/
content/article/2007/12/10/AR2007121000176.html


Biotech News
AZhttp, Inc.
Biotechnology Marketing